← Back to Search

COVID-19 Testing Home-based (Aim 1) for Coronavirus

N/A
Waitlist Available
Led By Susan M Kiene, PhD
Research Sponsored by San Diego State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American, Arabic speaking, Filipino, and Latino/a populations
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, expected to be 20 months
Awards & highlights

Study Summary

To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, expected to be 20 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, expected to be 20 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Test uptake
Secondary outcome measures
Test Impact (COVID-19 diagnoses)
Test Impact (number needed to screen)
Test access

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Mobile testing approach 2 (Aim 2)Experimental Treatment1 Intervention
Mobile testing utilizing baseline outreach approaches
Group II: Mobile testing approach 1 (Aim 2)Experimental Treatment1 Intervention
Mobile testing utilizing active outreach
Group III: At home testing (Aim 1)Experimental Treatment1 Intervention
High-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker.
Group IV: Mobile testing (Aim 1)Active Control1 Intervention
High-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing.

Find a Location

Who is running the clinical trial?

San Diego State UniversityLead Sponsor
153 Previous Clinical Trials
44,481 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,662 Previous Clinical Trials
40,883,881 Total Patients Enrolled
Susan M Kiene, PhDPrincipal InvestigatorSan Diego State University
2 Previous Clinical Trials
413 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Communities Fighting COVID-19!
Susan M Kiene 2020. "Communities Fighting COVID-19!". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05148936.
~9509 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top